Foundation Medicine Completes $42.5M Round of Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Foundation Medicine has completed a $42.5 million Series B round of financing, the Cambridge, Mass.-based firm announced today.

Investors in the round included Deerfield Management, Casdin Capital, Redmile Group, Roche Venture Fund, and WuXi Corporate Venture Fund, along with founding investor Third Rock Ventures and current venture capital backers Google Ventures and Kleiner Perkins Caufield & Byers. An undisclosed fund and an undisclosed strategic investor also participated in the round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.